Samsung In Talks To Acquire Biotech Firm Biogen In A US$42 Billion Deal
The Samsung Group is reportedly in negotiations to acquire biotech firm Biogen (Nasdaq: BIIB). The US firm approached the South Korean
Read moreThe Samsung Group is reportedly in negotiations to acquire biotech firm Biogen (Nasdaq: BIIB). The US firm approached the South Korean
Read more